Sickle Cell Disease News

Home
Sickle Cell Disease News

Sickle Cell Anemia News is a digital platform providing daily updates on research, science and advic
(30)

04/01/2024

A small proof-of-concept trial evaluating motixafortide for stem cell mobilization in sickle cell disease (SCD) has dosed its first patient. https://buff.ly/48JqZ9Z

28/12/2023

Columnist Mary Shaniqua was thrilled by the news of the sickle cell "cure," Casgevy, but with time she balanced that emotion with reality. https://buff.ly/3H0LPG4

28/12/2023

The holiday season can be rife with triggers for a sickle cell pain crisis. Here's how columnist Oluwatosin Adesoye has learned to manage.

https://buff.ly/3tqp3nL

26/12/2023

A scientist behind Casgevy, the gene-editing therapy for sickle cell disease, say its recent approval in the U.S. marks an historic moment.

https://buff.ly/4aoQuPk

20/12/2023

After a median of three years of follow-up, 88% of the sickle cell patients evaluated after treatment with Lygenia gene therapy had no VOEs.

https://buff.ly/3tqcMQ6

20/12/2023

The holiday season can be rife with triggers for a sickle cell pain crisis. Here's how columnist Oluwatosin Adesoye has learned to manage. https://buff.ly/480q0SG

19/12/2023

A European Medicines Agency committee supported Casgevy to treat sickle cell and beta thalassemia; final approval decision due in February. https://buff.ly/3Ny5jW2

14/12/2023

As a physician, columnist Sylvia Amuta is a believer in pharmaceutical medicine, but natural remedies have recently caught her attention.

https://buff.ly/486Q3qW

13/12/2023

As a physician, columnist Sylvia Amuta is a believer in pharmaceutical medicine, but natural remedies have recently caught her attention. https://buff.ly/41jqMaM

13/12/2023

Columnist Oluwatosin Adesoye spent decades denying that her sickle cell disease was a disability. That's common and regrettable, she writes. https://buff.ly/3uZtpmg

12/12/2023

After a median of three years of follow-up, 88% of the sickle cell patients evaluated after treatment with Lygenia gene therapy had no VOEs. https://buff.ly/3uTY58v

09/12/2023

Here is this week's most-read article featured on our website! Are you caught up?

The CRISPR-based therapy, now called Casgevy, is the first gene-editing therapy for sickle cell disease and a similar blood disorder.

https://buff.ly/4181KeC

08/12/2023

The FDA has approved lovotibeglogene autotemcel, a gene therapy from Bluebird Bio known as lovo-cel, for treating SCD patients ages 12 and older who have a history of painful VOCs. Read more: https://bit.ly/48rValZ

08/12/2023

Casgevy has become the first cell-based gene therapy employing CRISPR/Cas9, a type of gene-editing technology, to win approval in the U.S. Read more: https://bit.ly/3tbp4M5

08/12/2023

Columnist Mary Shaniqua shares the techniques that offer her relief from sickle cell pain, which is especially important as winter nears. https://buff.ly/4a8ZrMG

07/12/2023

In red blood cell exchange transfusions, sickled cells are removed from a patient’s blood, then replaced with healthy ones from donors. https://buff.ly/3NcfC20

07/12/2023

Advancements in treatment for sickle cell disease are exciting, but not if patients can't access them, writes columnist Oluwatosin Adesoye.

https://buff.ly/3TbR0de

02/12/2023

Here is this week's most-read article featured on our website! Are you caught up?

A first person with severe sickle cell is to be treated soon with BEAM-101, a gene editing cell therapy, in an enrolling Phase 1/2 trial.

https://buff.ly/3t87Cbc

01/12/2023

As a physician, columnist Sylvia Amuta is a believer in pharmaceutical medicine, but natural remedies have recently caught her attention. https://buff.ly/3R0OofL

01/12/2023

Having a child with sickle cell disease can prompt many emotions, including parental guilt, says columnist Oluwatosin Adesoye.

https://buff.ly/3N9hQ1Q

30/11/2023

Skin grafts can ease pain associated with leg ulcers, improve wound healing, and reduce the need for pain meds in sickle cell patients, a study finds. https://buff.ly/3uIfT6s

29/11/2023

Advancements in treatment for sickle cell disease are exciting, but not if patients can't access them, writes columnist Oluwatosin Adesoye. https://buff.ly/47CYrii

28/11/2023

A project designed to test AB Science’s masitinib as a sickle cell treatment has been awarded €9.2 million in public funding in France. https://buff.ly/3sXYbLx

27/11/2023

Columnist Dunstan Nicol-Wilson offers some observations as a mentor to children with sickle cell disease, after speaking with their parents. https://buff.ly/49RW4cR

25/11/2023

Here is this week's most-read article featured on our website! Are you caught up?

An FDA advisory committee met to discuss the gene editing therapy exa-cel ahead of an expected agency decision in December on its approval.

https://buff.ly/3MYydhE

23/11/2023

Columnist Dunstan Nicol-Wilson is driven toward personal growth and better quality of life, but sometimes he needs to push himself to do it.

https://buff.ly/3SRJSTe

21/11/2023

The CRISPR-based therapy, now called Casgevy, is the first gene-editing therapy for sickle cell disease and a similar blood disorder. https://buff.ly/3um82el

20/11/2023

A first person with severe sickle cell is to be treated soon with BEAM-101,
a gene editing cell therapy, in an enrolling Phase 1/2 trial. https://buff.ly/49GS276

18/11/2023

Here is this week's most-read article featured on our website! Are you caught up?

Bluebird announced that it has entered into an advanced agreement to sell the priority review voucher if the FDA does approve lovo-cel.

https://buff.ly/40zZgWh

16/11/2023

Young people with kidney failure due to sickle cell disease wait longer for a kidney transplant and have higher mortality, a study found. https://buff.ly/3MQgwkn

Address

Website

http://sicklecellanemianews.com/

Alerts

Be the first to know and let us send you an email when Sickle Cell Disease News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Videos

New FDA Approval for treating Sickle Cell Disease

New FDA Approval for Sickle Cell Disease therapy

Casgevy has become the first cell-based gene therapy employing CRISPR/Cas9, a type of gene-editing technology, to win approval in the U.S. Read more: https://bit.ly/3tbp4M5 #sicklecell #sicklecelldisease #sicklecellanemia #FDAApproval

AWIR% Learning From Each Other

Patient advocate Liza Bernstein explains how #AWindowIntoRare will highlight what we can learn from each other as members of the #raredisease community. Join #BioNews in an online panel discussion + Q&A on #RareDiseaseDay at 3 p.m. EST Feb 28. Register: https://bit.ly/Bionews_RegisterNow

Rare Disease Day - A Window Into Rare

Patient advocate Liza Bernstein gives some insight into what will be discussed during "A Window Into Rare," our #RareDiseaseDay online panel discussion on Feb. 28. Register for this live event here: https://bit.ly/Bionews_RegisterNow #AWindowIntoRare #BioNews

sicpromo5a

FORUMS IG STORIES16

sicpromo5a

sicpromo4a

sicpromo2a

sicpromo5a

sicpromo4a

Shortcuts

Address
Alerts
Videos
Claim ownership or report listing
Want your business to be the top-listed Media Company?

Country:

City:

04/01/2024

28/12/2023

28/12/2023

26/12/2023

20/12/2023

20/12/2023

19/12/2023

14/12/2023

13/12/2023

13/12/2023

12/12/2023

09/12/2023

08/12/2023

08/12/2023

08/12/2023

07/12/2023

07/12/2023

02/12/2023

01/12/2023

01/12/2023

30/11/2023

29/11/2023

28/11/2023

27/11/2023

25/11/2023

23/11/2023

21/11/2023

20/11/2023

18/11/2023

16/11/2023

Address

Website

Alerts

Videos

New FDA Approval for treating Sickle Cell Disease

New FDA Approval for Sickle Cell Disease therapy

AWIR% Learning From Each Other

Rare Disease Day - A Window Into Rare

sicpromo5a

FORUMS IG STORIES16

sicpromo5a

sicpromo4a

sicpromo2a

sicpromo5a

sicpromo4a

sicpromo4a

sicpromo4a

Shortcuts

Share